China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients.

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and raise health-care costs for patients, some drug trade groups warn. They also said the import taxes could strain cash-strapped generic drugmakers and distributors.

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic drugs in the United States and exacerbate drug shortages, experts say.

Trump initiated the sweeping tariffs to “hold Mexico, Canada, and China accountable to their promises of halting illegal immigration and stopping poisonous fentanyl and other dr

Americans found it harder to find drugs like Tamiflu or inhalers with albuterol because the manufacturers were having a harder time getting their hands on the raw ingredients for those medicines, which can come from all over the world.